References
Zhang L, Wang SA (2014) A focused review of hematopoietic neoplasms occurring in the therapy-related setting. Int J Clin Exp Pathol 7:3512–3523
Chen W, Wang E, Lu Y, Gaal KK, Huang Q (2010) Therapy-related acute lymphoblastic leukemia without 11q23 abnormality: report of six cases and a literature review. Am J Clin Pathol 133:75–82
Cambier N, Renneville A, Cazaentre T et al (2008) JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders. Leukemia 22:1454–1455
Aguiar RC (1998) Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisal. Leuk Lymphoma 29:17–26
Zahra K, Ben Fredj W, Ben Youssef Y et al (2012) Chronic myeloid leukemia as a secondary malignancy after lymphoma in a child. A case report and review of the literature. Onkologie 35:690–693
Demiriz IS, Tekgunduz E, Bozdag SC, Altuntas F (2014) Chronic myeloid leukemia as a secondary malignancy following treatment of diffuse large B-cell lymphoma. Turk J Haematol 31:92–94
Xu XH, Huang LS, Yang J et al (2013) Chronic myeloid leukemia arising from acute myeloid leukemia: response to imatinib mesylate with favorable outcome. Leuk Lymphoma 54:195–197
Lee HY, Lee KH, Hyun MS, Kim MK, Koh SA, Cho HS (2014) Chronic myeloid leukemia as a secondary malignancy after diffuse large B-cell lymphoma. Korean J Intern Med 29:250–252
Menon NM, Katsanis E, Khalpey Z, Whitlow P (2015) Pediatric secondary chronic myeloid leukemia following cardiac transplantation for anthracycline-induced cardiomyopathy. Pediatr Blood Cancer 62:166–168
Malfuson JV, Konopacki J, Fagot T et al (2011) Therapy-related myeloproliferative neoplasm with ETV6-PDGFRB rearrangement following treatment of acute promyelocytic leukemia. Ann Hematol 90:1477–1479
Jabbour E, Kantarjian HM, Abruzzo LV et al (2007) Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Blood 110:2991–2995
Kovitz C, Kantarjian H, Garcia-Manero G, Abruzzo LV, Cortes J (2006) Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia. Blood 108:2811–2813
Ramanarayanan J, Dunford LM, Baer MR, Sait SN, Lawrence W, McCarthy PL (2006) Chronic myeloid leukemia after treatment of lymphoid malignancies: response to imatinib mesylate and favorable outcomes in three patients. Leuk Res 30:701–705
Waldman D, Weintraub M, Freeman A, Neumann Y, Rechavi G, Toren A (2004) Favorable early response of secondary chronic myeloid leukemia to imatinib. Am J Hematol 75:217–219
Acknowledgments
We thank Steven Conlon in the Department of Pathology at Duke University Medical Center for the technical assistance of photo images and figure illustration.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Financial disclosure
None reported.
Rights and permissions
About this article
Cite this article
Wu, B., Ingersoll, K., Rehder, C. et al. Sequential development of chronic myelogenous leukemia and primary myelofibrosis in a patient with history of large B-cell lymphoma treated with radiotherapy and chemotherapy: two myeloid neoplasms with distinct genotypic profiles suggestive of biclonality in a single individual. Ann Hematol 95, 1383–1386 (2016). https://doi.org/10.1007/s00277-016-2707-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-016-2707-x